Publication|Articles|November 17, 2026

Pharmacy Practice in Focus: Health Systems

  • November 2026
  • Volume 15
  • Issue 6

Pharmacist Burnout Poses Challenges to Patient Access

Listen
0:00 / 0:00

Key Takeaways

  • Multiple datasets demonstrate high burnout prevalence among pharmacists, with emotional exhaustion most prominent, and consistent associations with turnover intent, reduced satisfaction, and career-change consideration.
  • Expanded scope in immunization, MTM, chronic disease support, and point-of-care services has intensified workload, making workforce sustainability increasingly central to access-to-care capacity.
SHOW MORE

Preserving patient access requires attention to the people, workflows, and financial structures behind the pharmacy counter, not just the number of open pharmacy locations.

Pharmacist burnout has moved beyond an individual well-being concern and become a workforce issue with implications for patient access. Patel and colleagues surveyed 412 community pharmacists and reported that 74.9% experienced burnout in at least 1 domain of the Maslach Burnout Inventory. Emotional exhaustion affected 68.9%, depersonalization affected 50.4%, and reduced personal accomplishment affected 30.7%.1 Dee and colleagues analyzed 19 studies involving 11,306 pharmacists and reported a pooled burnout prevalence of 51%.2 Jones and colleagues similarly reported burnout symptoms among 61.2% of hospital clinical pharmacy practitioners.3

These findings have appeared during a period when pharmacists have taken on expanded responsibilities, including immunization, medication therapy management, chronic disease support, point-of-care testing, and public health services (Table).1-12

About the Author

Alberto Coustasse, DrPH, MD, MBA, MPH, is a professor of health care management and administration at the Lewis College of Business at Marshall University.

Disclosures

The author has nothing to disclose.

Workforce and Operational Pressure

Workforce sustainability has become a growing concern. Burnout has been associated with turnover intentions, lower professional satisfaction, and consideration of career changes.1-3 The US Bureau of Labor Statistics has projected approximately 14,200 pharmacist job openings annually from 2024 to 2034 because of retirements, occupational transitions, and replacement needs.4

Operational strain may appear as prescription backlogs, longer wait times, reduced appointment availability, shorter operating hours, and decreased capacity for patient counseling or clinical services. These indicators matter because pharmacies are among the most accessible health care settings for patients.

Pharmacy Deserts, Closures, and Access Vulnerability

The access implications of pharmacist burnout deserve closer attention. Pharmacy deserts have usually been described as geographic access problems, but the issue may be broader than physical distance alone. A pharmacy can remain open and still provide diminished access if it has unstable staffing, limited hours, reduced appointment capacity, or insufficient time for counseling and clinical services (Table).1-12

Wittenauer and colleagues estimated that 15.8 million Americans live in pharmacy deserts.7 Using broader criteria, Mathis and colleagues estimated that 57.1 million Americans live in pharmacy deserts and that another 28.9 million depend on a single keystone pharmacy for medication access.8 These numbers suggest that pharmacy access vulnerability extends well beyond communities with no nearby pharmacy.

A real-world example is evident in recent retail pharmacy closures. When a chain pharmacy closes in a rural or low-income area, patients may need to travel farther, transfer prescriptions, find new immunization sites, or rely on a remaining pharmacy with existing workforce constraints. The closure itself may be the most visible event, but patients may have experienced reduced service capacity before the doors closed.

Access concerns extend beyond medication dispensing. Community pharmacies have increasingly served as locations for adult immunizations, medication therapy management, chronic disease education, and preventive health services. According to the CDC, Federal Retail Pharmacy Program participants administered more than 307.4 million COVID-19 vaccine doses by August 18, 2023, and retail pharmacies administered approximately 36.4 million adult influenza vaccine doses during the 2025-2026 season.9,10 Communities experiencing pharmacy workforce shortages may therefore face challenges that extend beyond prescription access alone. Patients seeking vaccinations, medication reviews, adherence support, or preventive services may experience longer wait times or reduced service availability when staffing resources are constrained. Recent national research has also documented the broader access implications of pharmacy closures. Guadamuz and colleagues reported that approximately 12.8% of US pharmacies closed between 2009 and 2015, with closures occurring more frequently among independent pharmacies and communities characterized by socioeconomic disadvantage.11 These findings suggest that pharmacy access concerns may be particularly relevant for populations that already experience barriers to health care services.

There is also uncertainty in estimates of pharmacy deserts. Different studies may use different definitions, distance thresholds, transportation assumptions, and population measures. Some estimates may emphasize urban walking distance, whereas others may focus on rural driving distance, travel time, or dependence on a single pharmacy. Therefore, pharmacy desert figures should be interpreted as national access warning indicators rather than exact counts of patients unable to obtain medications.

Policy Implications

Policy discussions should extend beyond maintaining pharmacy operations to ensure adequate staffing, reimbursement, workflow support, and protected clinical time for pharmacists to provide safe, meaningful access.

Potential strategies include staffing benchmarks, expanded use of technicians, workflow redesign, reimbursement for clinical services, and routine monitoring of vacancy rates, turnover, overtime, and burnout indicators. Pharmacist burnout should therefore be viewed as both a workforce and access-to-care issue. The National Academies of Sciences, Engineering, and Medicine has framed clinician burnout as a systems concern related to quality, safety, patient experience, and workforce sustainability.12 For pharmacy leaders, the practical message is straightforward: Preserving access requires attention to the people, workflows, and financial structures behind the pharmacy counter, not only the number of open pharmacy locations. A dashboard that combines staffing, service availability, and access measures may give pharmacy leaders earlier warning when a pharmacy is physically open but functionally strained, especially in rural and medically underserved communities.

REFERENCES
1. Patel SK, Kelm MJ, Bush PW, Lee HJ, Ball AM. Prevalence and risk factors of burnout in community pharmacists. J Am Pharm Assoc (2003). 2021;61(2):145-150. doi:10.1016/j.japh.2020.09.022
2. Dee J, Dhuhaibawi N, Hayden JC. A systematic review and pooled prevalence of burnout in pharmacists. Int J Clin Pharm. 2023;45(5):1027-1036. doi:10.1007/s11096-022-01520-6
3. Jones GM, Roe NA, Louden L, Tubbs CR. Factors associated with burnout among US hospital clinical pharmacy practitioners: results of a nationwide pilot survey. Hosp Pharm. 2017;52(11):742-751. doi:10.1177/0018578717732339
4. Pharmacists: occupational outlook handbook. US Bureau of Labor Statistics. Accessed June 13, 2026. https://www.bls.gov/ooh/healthcare/pharmacists.htm
5. Catanzano S, Gemmellaro JN, Gross MM, Fahmy M, Payne GH, Lee KC. Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States. Ment Health Clin. 2025;15(3):150-155. doi:10.9740/mhc.2025.06.150
6. Qato DM, Alexander GC, Chakraborty A, Guadamuz JS, Jackson JW. Association between pharmacy closures and adherence to cardiovascular medications among older US adults. JAMA Netw Open. 2019;2(4):e192606. doi:10.1001/jamanetworkopen.2019.2606
7. Wittenauer R, Shah PD, Bacci JL, Stergachis A. Locations and characteristics of pharmacy deserts in the United States: a geospatial study. Health Aff Sch. 2024;2(4):qxae035. doi:10.1093/haschl/qxae035
8. Mathis WS, Berenbrok LA, Kahn PA, Appolon G, Tang S, Hernandez I. Vulnerability index approach to identify pharmacy deserts and keystone pharmacies. JAMA Netw Open. 2025;8(3):e250715. doi:10.1001/jamanetworkopen.2025.0715
9. The Federal Retail Pharmacy Program for COVID-19 Vaccination. CDC. Updated August 18, 2023. Accessed June 13, 2026. https://archive.cdc.gov/www_cdc_gov/vaccines/covid-19/retail-pharmacy-program/index.html
10. Weekly flu vaccination dashboard. CDC. Accessed June 13, 2026. https://www.cdc.gov/fluvaxview/dashboard/index.html
11. Guadamuz JS, Alexander GC, Zenk SN, Qato DM. Assessment of pharmacy closures in the United States from 2009 through 2015. JAMA Intern Med. 2020;180(1):157-160. doi:10.1001/jamainternmed.2019.4588
12. National Academies of Sciences, Engineering, and Medicine. Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being. National Academies Press; 2019. doi:10.17226/25521

Related to this article